| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/11/2005 | WO2005073236A2 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 08/11/2005 | WO2005072763A1 Liver fibrosis inhibitor |
| 08/11/2005 | WO2005046588A3 Compounds, compositions, and methods |
| 08/11/2005 | WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 08/11/2005 | US20050176993 Urokinase inhibitors, production and use thereof |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176941 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof |
| 08/11/2005 | US20050176934 Antibody combination useful for tumor therapy |
| 08/11/2005 | US20050176933 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176825 a mixture of quinic acid and salts, and nontoxic inert carriers or diluents; solvent extraction |
| 08/11/2005 | US20050176824 Novel substance having antitumor/anti-inflammatory activity |
| 08/11/2005 | US20050176821 Meta-substituted phenylene sulphonamide derivatives |
| 08/11/2005 | US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176811 Vitamin combination for providing protection during the chemotherapy and/or radio-therapy of malignant tumours |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176787 Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth |
| 08/11/2005 | US20050176780 2,5-disubstituted 3-mercaptopentanoic acid |
| 08/11/2005 | US20050176779 dioxodihydropyridine derivatives and certain methacrylic acid and furan derivative precursors thereof; use as tumor growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/11/2005 | US20050176764 Medicine for treating cancer |
| 08/11/2005 | US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176753 controlling signal transduction; anticancer agents; antitumor agnets; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 08/11/2005 | US20050176746 Treating eating disorders and digestive disorders wth loperamide |
| 08/11/2005 | US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma |
| 08/11/2005 | US20050176740 Synergistic for cancer characterized by ras oncogene overexpression; N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine |
| 08/11/2005 | US20050176737 Mitotic kinesin inhibitors |
| 08/11/2005 | US20050176725 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide; antitumor; antiproliferative agent; synergistic therapy for resistant; Bcr/Abl, leukemia |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176719 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176712 Integrin expression inhibitor |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176702 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | US20050176691 Combination therapy for the treatment of estrogen-sensitive disease |
| 08/11/2005 | US20050176685 Administering bisphosphonate compounds such as ibandronate, minodronate, pamidronate, risedronate, zoledronate, and alendronate; osteoporosis |
| 08/11/2005 | US20050176678 Compounds and method for coating surfaces in a haemocompatibe manner |
| 08/11/2005 | US20050176673 guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza compounds, or cytosin-1-yl - ethoxymethanephosphonic acid derivatives, used to treat osteoporosis and other disorders of bone metabolism, cancer, or viral infections |
| 08/11/2005 | US20050176672 Use of cationic lipids to generate anti-tumor immunity |
| 08/11/2005 | US20050176671 Drug screening; competitive binding; antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; receptor binding assay, gene expression |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176647 Having an alkylation site via a vinyl linker at the end of a pyrrole-imidazole polyamide; inhibits the expression of a specific gene; high anti-cancer activity |
| 08/11/2005 | US20050176632 Angiogenesis inhibitors |
| 08/11/2005 | US20050176619 N-[[1-[[2-(diethylamino)ethyl]amino]-7-methoxy-9-oxothioxanthen-4-yl]-methyl]formamide, or a pharmaceutically acceptable acid-addition salt thereof, and to the method of use thereof in the treatment of tumors and cancers. |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050176060 Crystal structure |
| 08/11/2005 | US20050176044 Polynucleotides and polypeptides encoding receptors |
| 08/11/2005 | US20050176018 Increased nuclease resistance; gene expression inhibition |
| 08/11/2005 | US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics |
| 08/11/2005 | US20050175711 Shark cartilage extracts and use thereof for immunomodulation |
| 08/11/2005 | US20050175702 Contains magnetic and/or metallic colloids; produced by suspension polymerization |
| 08/11/2005 | US20050175639 Methods |
| 08/11/2005 | US20050175632 Vaccine for preventing cervical cancer |
| 08/11/2005 | US20050175606 Cyclic single-chain trispecific antibody |
| 08/11/2005 | US20050175596 Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells |
| 08/11/2005 | US20050175587 Inhibits cancer cell growth especially epithelial cancer cell growth; host cell and a drug containing the vector; for the treatment of cancers, by gene therapy |
| 08/11/2005 | US20050175582 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 08/11/2005 | US20050175580 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
| 08/11/2005 | US20050175555 2,4,6,8,10,12,14-hexadecaheptaenol in cyclodextrins; antitumor , antiinflammatory, antiaging, antiprolifrative agent, antioxident; activation of free radical production, cardiovascular disorders, atherosclerosis; cosmetic and pharmaceutical use |
| 08/11/2005 | DE10138561B4 Tumorhemmende Cerverbindungen sowie deren Verwendung Tumor-inhibiting cerium compounds and their use |
| 08/11/2005 | CA2609888A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation |
| 08/11/2005 | CA2554749A1 P2x receptor inhibitor |
| 08/11/2005 | CA2554735A1 Therapeutic and carrier molecules |
| 08/11/2005 | CA2554733A1 Method for producing sorbicillactone a |
| 08/11/2005 | CA2554025A1 Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof |
| 08/11/2005 | CA2553455A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis |
| 08/11/2005 | CA2553318A1 Pyranone derivatives useful for treating cancer |
| 08/11/2005 | CA2552918A1 Gossypol derivatives, production method thereof and uses of same |
| 08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
| 08/10/2005 | EP1561815A2 Tissue-specific and target rna-specific ribozymes |
| 08/10/2005 | EP1561759A1 Cell death-inducing agent |
| 08/10/2005 | EP1561753A2 Benzo[b]chromenonapthyridin-7-one and pyrano[2',3':7,8]quino[2,3-b]Quinoxalin-7-one derivatives, process of synthesis, pharmaceutical compositions and their antitumoral properties for the treatment of cancer |
| 08/10/2005 | EP1561471A1 Cell growth regulator |
| 08/10/2005 | EP1561464A2 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 08/10/2005 | EP1561425A1 Indocyanine dyes |
| 08/10/2005 | EP1560854A2 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 08/10/2005 | EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 08/10/2005 | EP1560837A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 08/10/2005 | EP1560832A1 Pyrimido 4,5-d pyrimidine derivatives with anticancer activity |
| 08/10/2005 | EP1560829A1 Pyrimido compounds having antiproliferative activity (ii) |
| 08/10/2005 | EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 08/10/2005 | EP1560826A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 08/10/2005 | EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 08/10/2005 | EP1560817A1 Methods and compositions of novel triazine compounds |
| 08/10/2005 | EP1560596A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
| 08/10/2005 | EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |